Berg AR, et al. - Considering the significance of early rehabilitation following arthroplasty (TJA), researchers examined the efficacy of transdermal scopolamine in reducing rates of postoperative nausea and vomiting (PONV) and improving functional outcomes following TJA. The charts of 1,580 consecutive patients who underwent TJA between 2014 and 2017 were retrospectively reviewed and a comparison was performed between patients prior to the addition of the scopolamine patch (control group) and those after the addition (study group). Outcomes suggest achievement of a significant reduction in PONV and improvement in functional outcomes following TJA in correlation to the use of a scopolamine patch. Data thereby support using transdermal scopolamine as part of a multimodal, perioperative pain protocol in these patients.